In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Investment miscues can be just as important as successes, provided we carry lessons away from them.
These names frequently trade at low multiples to current assets and may (but may not) be worthy of purchase.
Just five non-biotech names trade below net current asset value.
Searching for value plays produces few options, right now.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.